当前位置:首页 - 行情中心 - 浙江医药(600216) - 财务分析

浙江医药

(600216)

  

流通市值:141.74亿  总市值:141.75亿
流通股本:9.62亿   总股本:9.62亿

浙江医药(600216)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年半年度实现净利润6.25亿元,每股收益0.70元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年半年度最新股东权益1138999.54万元,未分配利润660652.93万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年半年度最新总资产1420190.95万元,负债281191.42万元。

利润表
报告期2025-06-302025-03-312024-12-312024-09-30
营业总收入4,322,874,759.832,255,389,182.259,375,216,922.057,112,804,346.3
营业总成本3,511,652,540.631,778,067,510.037,934,024,498.036,103,341,032.99
其他经营收益
营业利润761,999,585.03454,250,358.651,223,110,445.3937,076,246.21
利润总额758,881,420.16453,782,461.451,212,282,187.41930,805,265.38
净利润624,571,156.24385,252,415.31,020,251,510.18758,558,082.68
每股收益
其他综合收益28,286,096.289,122,458.68-7,635,393.08-1,441,540.27
综合收益总额652,857,252.52394,374,873.981,012,616,117.1757,116,542.41
资产负债表
报告期2025-06-302025-03-312024-12-312024-09-30
流动资产:
流动资产合计7,114,739,673.496,811,951,484.566,584,941,036.576,146,702,104.36
非流动资产:
非流动资产合计7,087,169,849.017,184,701,913.077,210,532,069.127,282,810,008.95
资产总计14,201,909,522.513,996,653,397.6313,795,473,105.6913,429,512,113.31
流动负债:
流动负债合计2,384,856,722.852,386,933,768.282,569,444,450.432,358,145,040.77
非流动负债:
非流动负债合计427,057,436.43343,753,324.51358,086,415.36461,965,749.34
负债合计2,811,914,159.282,730,687,092.792,927,530,865.792,820,110,790.11
所有者权益(或股东权益):
归属于母公司股东权益合计11,214,681,567.5111,067,801,751.7210,648,142,085.0610,341,301,291.01
股东权益合计11,389,995,363.2211,265,966,304.8410,867,942,239.910,609,401,323.2
负债和股东权益合计14,201,909,522.513,996,653,397.6313,795,473,105.6913,429,512,113.31
现金流量表
报告期2025-06-302025-03-312024-12-312024-09-30
经营活动产生的现金流量:
经营活动现金流入小计4,933,125,935.972,410,514,065.329,130,924,502.026,962,388,408.79
经营活动现金流出小计4,134,944,730.932,105,549,414.327,907,625,860.076,270,328,271.84
经营活动产生的现金流量净额798,181,205.04304,964,6511,223,298,641.95692,060,136.95
投资活动产生的现金流量:
投资活动现金流入小计909,447,045.65472,919,982.851,211,707,968.83949,820,843.47
投资活动现金流出小计1,036,475,006.73591,343,225.751,685,207,838.411,233,043,731.02
投资活动产生的现金流量净额-127,027,961.08-118,423,242.9-473,499,869.58-283,222,887.55
筹资活动产生的现金流量:
筹资活动现金流入小计495,000,000185,000,000520,000,000485,000,000
筹资活动现金流出小计486,767,481.42142,771,240.27775,320,876.26732,293,731.81
筹资活动产生的现金流量净额8,232,518.5842,228,759.73-255,320,876.26-247,293,731.81
汇率变动对现金及现金等价物的影响63,636,449.1822,827,650.8311,267,874.7614,146,462.78
现金及现金等价物净增加额743,022,211.72251,597,818.66505,745,770.87175,689,980.37
期末现金及现金等价物余额2,708,607,622.782,217,183,229.721,965,585,411.061,635,529,620.56
补充资料:
现金及现金等价物的净增加额743,022,211.72-505,745,770.87-
最新报告期:2025-09-02
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
长城证券王彤,肖亚平1.161.581.702025-09-02
光大证券蔡嘉豪,赵乃迪1.021.101.192025-08-28
中金公司侯一林,裘孝锋,贾雄伟1.141.14--2025-08-26
TOP↑